H.C. Wainwright raised the firm’s price target on Monopar Therapeutics (MNPR) to $22 from $6 and keeps a Buy rating on the shares. The ...

The Mayor of Greater Manchester has visited Cambridge to back a new partnership aimed at encouraging innovation and boosting economic growth.

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...

Modular Devices is excited to announce the addition of David Frank as Fractional Chief Commercial Officer, reinforcing the company's commitment to strategic growth and leadership within the cleanroom ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous ...

AstraZeneca has revealed that its top executive in China, Leon Wang, has been detained by Chinese authorities, after ...

Total revenues for the company the last quarter was $134 million, a 7% decrease from last year. Register now to see our 7 Best Stocks for the Next 30 Days report - free today! Ionis Pharmaceuticals ...

Pharmaceutical giant AstraZeneca said that the head of its China operations had been detained, after reports the firm was ...

The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...